A Positron Emission Tomography/Computed Tomography (PET/CT) Bone Imaging Study in Patients Receiving Enzalutamide for Castration-Resistant Prostate Cancer (CRPC)
Condition(s):Prostate Carcinoma Metastatic to the Bone; Castration Resistant Prostate CancerLast Updated:May 5, 2020Completed